Literature DB >> 12906861

Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss.

Vincent Ling1, Paul W Wu, Vikki Spaulding, Jan Kieleczawa, Deborah Luxenberg, Beatriz M Carreno, Mary Collins.   

Abstract

B7-H3 is a novel protein structurally related to the B7 family of ligands by the presence of a single set of immunoglobulin-V-like and immunoglobulin-C-like (VC) domains. By multiplex PCR, the dominantly expressed form of human B7-H3 was found to be a splice variant containing tandemly duplicated VC domains (VCVC). In contrast, mouse B7-H3 cDNA contained only one single VC form due to an exon structure corresponding to V-(pseudoexon C)-(pseudoexon V)-C. Comparisons of human, monkey, mouse, and hamster genomic B7-H3 reveal that primates, but not rodents, exhibited a higher degree of intramolecular sequence similarity between VC duplications than between molecules. Both VC and VCVC forms of human B7-H3 inhibited CD4(+) T cell proliferation and downregulated cytokine production upon TCR activation. These results suggest independent, but convergent, paths of B7-H3 active domain duplication followed by divergent histories of exon degeneration in rodents and exon maintenance by humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906861     DOI: 10.1016/s0888-7543(03)00126-5

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  64 in total

1.  The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization.

Authors:  W-K Suh; S X Wang; A H Jheon; L Moreno; S K Yoshinaga; B Ganss; J Sodek; M D Grynpas; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-18       Impact factor: 11.205

Review 2.  Immunotherapies for bladder cancer: a new hope.

Authors:  Farhad Fakhrejahani; Yusuke Tomita; Agnes Maj-Hes; Jane B Trepel; Maria De Santis; Andrea B Apolo
Journal:  Curr Opin Urol       Date:  2015-11       Impact factor: 2.309

3.  The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta.

Authors:  Margaret G Petroff; Elza Kharatyan; Donald S Torry; Lesya Holets
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  The contrasting role of B7-H3.

Authors:  Kimberly A Hofmeyer; Anjana Ray; Xingxing Zang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

5.  Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.

Authors:  Paul L Crispen; Yuri Sheinin; Timothy J Roth; Christine M Lohse; Susan M Kuntz; Xavier Frigola; R Houston Thompson; Stephen A Boorjian; Haidong Dong; Bradley C Leibovich; Michael L Blute; Eugene D Kwon
Journal:  Clin Cancer Res       Date:  2008-08-11       Impact factor: 12.531

6.  A novel monoclonal antibody against mouse B7-H3 developed in rats.

Authors:  Ruhong Yan; Shun Yang; Jing Sun; Xuqin Chen; Guangbo Zhang; Ping Feng; Xueguang Zhang
Journal:  Hybridoma (Larchmt)       Date:  2012-08

7.  Murine b7-h3 is a co-stimulatory molecule for T cell activation.

Authors:  Ruhong Yan; Shun Yang; Aiping Gu; Fuqin Zhan; Chunyan He; Chenhao Qin; Xueguang Zhang; Ping Feng
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-12

8.  High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder.

Authors:  Zhili Xu; Ling Wang; Jianhua Tian; Hongwei Man; Pengfei Li; Baoen Shan
Journal:  Oncol Lett       Date:  2018-03-05       Impact factor: 2.967

9.  Structure and T cell inhibition properties of B7 family member, B7-H3.

Authors:  Vladimir Vigdorovich; Udupi A Ramagopal; Eszter Lázár-Molnár; Eliezer Sylvestre; Jun Sik Lee; Kimberly A Hofmeyer; Xingxing Zang; Stanley G Nathenson; Steven C Almo
Journal:  Structure       Date:  2013-04-11       Impact factor: 5.006

10.  Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

Authors:  Sangbin Lim; Hao Liu; Luciana Madeira da Silva; Ritu Arora; Zixing Liu; Joshua B Phillips; David C Schmitt; Tung Vu; Steven McClellan; Yifeng Lin; Wensheng Lin; Gary A Piazza; Oystein Fodstad; Ming Tan
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.